MDBMongoDB, Inc.
- Next report
- Dec 1
- Tuesday, in 19 days · after the market closes
- EPS expected
- $0.08
- quarter ending Oct 31, 2026
- Last result
- $1.32Beat
- vs −$0.30 expected on May 28
- Stock move on it
- +3.03%
- one session
- Price
- $339.89
- +0.52% today · $25.8B cap
Past and upcoming reports
2
| Dec 1, 2026 | Oct 31, 2026 | After the market closes | $0.08 | not yet | |
| May 28, 2026 | Apr 30, 2026 | After the market closes | −$0.30 | Beat$1.32 | +3.03% |
Pre-earnings read
No pre-earnings read for this report
None for this company right now.
After the report
May 28, 2026 report
MongoDB beats EPS by 11.5%, shares rise 1.76% amid strong growth but mixed quality signals
MongoDB reported Q2 EPS of $1.32 versus $1.18 estimate, an 11.5% beat. The stock rose 1.76% post-earnings, supported by strong revenue growth and high institutional ownership despite weak margins and capital efficiency. Forward catalysts include sustaining growth and margin improvement.
Reported against expected
MongoDB reported EPS of $1.32, beating the $1.18 consensus estimate by 11.5%.
Guidance
No explicit guidance provided in the payload. analyst consensus remains buy-tilted with a $399.82 target price.
How the stock reacted
Shares rose 1.76% to $354.41 on the day following the earnings beat, reflecting positive investor sentiment.
What changed
MongoDB beat EPS estimates by 11.5% with reported EPS of $1.32 versus $1.18 consensus.
What the price now assumes
The 1.76% stock rise reflects investor optimism on growth despite mixed quality and rich valuation.
What it means for the business
Investors should maintain a growth bias but monitor margin trends. watch for margin improvement signals.
The next one to three months, as we saw it then
Better case30%
Sustained revenue growth above 20% and margin improvement drive multiple expansion and share gains.
Base case50%
Growth remains steady around 20-25% with stable but negative margins, supporting current valuation.
Worse case20%
Margin pressure intensifies and growth slows, leading to valuation multiple contraction and share price decline.
If you hold it
Hold unless next-quarter revenue misses guidance materially or customer concentration risk worsens.
If you are watching
Add only if next-quarter guidance is reiterated or raised. avoid if guidance is cut or geopolitical risk escalates.
Scenario odds are a judgement, not measured.